You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Chris Viehbacher, CEO, Sanofi says the firm has been built so that it could grow without having to rely on the research and development of p...
Ahead of the Facebook IPO, the company wants to make privacy policies clear and simple, reports CNBC's Julia Boorstin. Scott Sandell of NEA,...
Cramer shares six stocks to watch, and reveals them in under 60 seconds.
CNBC's Seema Mody reports on the latest details of the FDA advisory panel's review of Arena Pharmaceuticals' anti-obesity drug.
The FMHR traders share their top trades of the hour. Jonathan Chaplin, Credit Suisse analyst, explains why his firm upgraded AT&T and Verizo...
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
